From recommendation to requirement: why multidisciplinary governance and centralization must become global standards in penile cancer care
DOI:
https://doi.org/10.2340/sju.v61.45436Keywords:
Penile squamous cell carcinoma, multidisciplinary tumor boards, centralization of care, volume-outcome relationship, guideline harmonization, quality indicatorsDownloads
References
Gerdtsson A, Abedi E, Baseckas G, et al. The Swedish national guidelines on penile cancer. Scand J Urol. 2025;60:189–194. https://doi.org/10.2340/sju.v60.44463 DOI: https://doi.org/10.2340/sju.v60.44463
Lebentrau S, May M. Centralization or individualization in penile cancer care: evidence, international insights, and a future framework for Germany. Urologie. 2025;64(12):1297–1306. https://doi.org/10.1007/s00120-025-02721-3 DOI: https://doi.org/10.1007/s00120-025-02721-3
Leitlinienprogramm Onkologie (German Cancer Society, German Cancer Aid, Association of the Scientific Medical Societies in Germany). S3 guideline for the diagnosis, treatment, and follow-up of penile cancer. Long version 1.0. AWMF Registry No. 043-042OL. Berlin; 2020. https://register.awmf.org/de/leitlinien/detail/043-042OL (accessed 30 January 2026)
EAU-ASCO Collaborative Guidelines on Penile Cancer. Presented at the EAU Annual Congress, Madrid, 2025. European Association of Urology Guidelines Office, Arnhem, The Netherlands.
National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: penile cancer. Version 1.2026. Plymouth Meeting, PA; 2025. https://www.nccn.org/professionals/physician_gls/pdf/penile.pdf (accessed 30 January 2026)
May M, Lebentrau S, Ayres B, et al. The goal of achieving high-quality surgical first-line therapy in patients with penile cancer is important; However, some collective efforts are still required in order to reach it. Comment on Brassetti et al. combined reporting of surgical quality and cancer control after surgical treatment for penile tumors with inguinal lymph node dissection: the Tetrafecta achievement. Curr Oncol. 2023, 30, 1882–1892. Curr Oncol. 2023;30(4):4269–4274. https://doi.org/10.3390/curroncol30040325 DOI: https://doi.org/10.3390/curroncol30040325
May M, Lebentrau S, Watkin N, et al. Initial presentation of the Pentafecta score as a quality instrument for outcome evaluation of primary surgical treatment in patients with penile cancer. Aktuelle Urol. 2023;54(4):292–298. https://doi.org/10.1055/a-2065-8256 DOI: https://doi.org/10.1055/a-2065-8256
Lebentrau S, Wakileh GA, Schostak M, et al. Does the identification of a minimum number of cases correlate with better adherence to international guidelines regarding the treatment of penile cancer? Survey results of the European PROspective Penile Cancer Study (E-PROPS). Front Oncol. 2021;11:759362. https://doi.org/10.3389/fonc.2021.759362 DOI: https://doi.org/10.3389/fonc.2021.759362
Boehm WU, Piontek D, Latarius S, et al. The clinical complexity of penile cancer: current clinical-epidemiological data from the database of the Free State of Saxony/Germany. Urol Int. 2022;106(7):706–715. https://doi.org/10.1159/000519210 DOI: https://doi.org/10.1159/000519210
Yakac A, Lebentrau S, Lusuardi L, et al. Centralizing penile cancer care in Germany and Austria: just a dream or a fast-approaching reality? Results of a survey study among urological department chairs and modeling of real treatment numbers of penile cancer patients. Urol Int. 2023;107(10–12):916–923. https://doi.org/10.1159/000534089 DOI: https://doi.org/10.1159/000534089
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Matthias May, Christian Gilfrich, Ingmar Wolff, Steffen Lebentrau
This work is licensed under a Creative Commons Attribution 4.0 International License.
As from Volume 59 (2024) all published articles, unless otherwise specified, are published under CC-BY license, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, with the condition of proper attribution to the original work.
